Format

Send to

Choose Destination
PLoS One. 2015 Mar 16;10(3):e0119688. doi: 10.1371/journal.pone.0119688. eCollection 2015.

Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study.

Author information

1
Research Unit of General Practice, Institute of Public Health, University of Southern Denmark, Odense, Denmark.
2
Centre for Pharmacoepidemiology, Karolinska Institutet, Department of Medicine Solna, Stockholm, Sweden.
3
Research Unit of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, Odense, Denmark.

Abstract

BACKGROUND:

Generic substitution means that one medicinal product is replaced by another product containing the same active substance. It is strictly regulated with respect to its bioequivalence, and all products must have undergone appropriate studies. Although generic substitution is widely implemented, it still remains to be answered how generic switch influences persistence to long-term treatment, and if it is modified by patients' concerns about medicine and views on generic medicine. This study focuses on users of antidepressants and antiepileptics, and their experience of generic switching.

METHODS:

The study was an observational cohort study. By use of a prescription database, we identified patients who had redeemed prescriptions on generically substitutable drugs, and a questionnaire was mailed to them. We analyzed predictors of discontinuation in relation to generic switch and patients' attitudes towards generic medicines and concerns about their medicine.

RESULTS:

Patients who experience their first-time switch of a specific drug were at higher risk of non-persistence, Hazard Ratio 2.98, 95% CI (1.81;4.89) versus those who have never switched, and 35.7% became non-persistent during the first year of follow-up. Generic switching did not influence persistence considerably in those having previous experience with generic switching of the specific drug. Stratified analyses on users of antidepressants and antiepileptics underpin the results, showing higher risk of non-persistence for first-time switchers for both drug categories.

CONCLUSION:

In conclusion, patients who are first-time switchers of a specific drug were at higher risk of non-persistence compared to never switchers and those having experienced previous generic switching.

PMID:
25775472
PMCID:
PMC4361595
DOI:
10.1371/journal.pone.0119688
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center